Joan A. Harrington

671 total citations
18 papers, 543 citations indexed

About

Joan A. Harrington is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Joan A. Harrington has authored 18 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Joan A. Harrington's work include Biochemical and Molecular Research (5 papers), Herpesvirus Infections and Treatments (3 papers) and HIV/AIDS drug development and treatment (3 papers). Joan A. Harrington is often cited by papers focused on Biochemical and Molecular Research (5 papers), Herpesvirus Infections and Treatments (3 papers) and HIV/AIDS drug development and treatment (3 papers). Joan A. Harrington collaborates with scholars based in United States, Australia and Sweden. Joan A. Harrington's co-authors include Thomas Spector, David Porter, T Spector, John E. Reardon, Y M Rustum, Martin Silink, Ilja Hulinsky, P de Miranda, Thimysta C. Burnette and B M Merrill and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Joan A. Harrington

18 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan A. Harrington United States 14 210 188 130 90 76 18 543
M. J. ROBINS United States 12 170 0.8× 311 1.7× 146 1.1× 164 1.8× 115 1.5× 30 638
Peter Hafkemeyer Germany 14 252 1.2× 300 1.6× 85 0.7× 144 1.6× 25 0.3× 22 604
Mark O. Palmier United States 15 128 0.6× 279 1.5× 96 0.7× 29 0.3× 39 0.5× 25 892
Marit Liland Sandvold Netherlands 15 222 1.1× 462 2.5× 68 0.5× 116 1.3× 68 0.9× 27 725
Takemitsu Nagahata Japan 15 162 0.8× 515 2.7× 229 1.8× 111 1.2× 66 0.9× 24 906
Jean Gauthier Canada 14 121 0.6× 204 1.1× 206 1.6× 194 2.2× 194 2.6× 31 728
Banmeet S. Anand United States 20 386 1.8× 344 1.8× 163 1.3× 103 1.1× 56 0.7× 38 1.0k
Victoria B. Knick United States 9 290 1.4× 434 2.3× 81 0.6× 108 1.2× 57 0.8× 10 833
Sumit Borah United States 11 329 1.6× 428 2.3× 196 1.5× 41 0.5× 48 0.6× 14 818
Zhaoyong Xi China 15 174 0.8× 302 1.6× 105 0.8× 182 2.0× 57 0.8× 31 616

Countries citing papers authored by Joan A. Harrington

Since Specialization
Citations

This map shows the geographic impact of Joan A. Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan A. Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan A. Harrington more than expected).

Fields of papers citing papers by Joan A. Harrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan A. Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan A. Harrington. The network helps show where Joan A. Harrington may publish in the future.

Co-authorship network of co-authors of Joan A. Harrington

This figure shows the co-authorship network connecting the top 25 collaborators of Joan A. Harrington. A scholar is included among the top collaborators of Joan A. Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan A. Harrington. Joan A. Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Elmgren, Anders, Rosella Mollicone, Marieta Costache, et al.. (1997). Significance of Individual Point Mutations, T202C and C314T, in the Human Lewis (FUT3) Gene for Expression of Lewis Antigens by the Human α(1,3/1,4)-Fucosyltransferase, Fuc-TIII. Journal of Biological Chemistry. 272(35). 21994–21998. 43 indexed citations
2.
Spector, T, et al.. (1995). Attenuation of the antitumor activity of 5-fluorouracil by (R)-5-fluoro-5,6-dihydrouracil.. PubMed. 55(6). 1239–41. 58 indexed citations
3.
Porter, David, et al.. (1995). Enzymatic elimination of fluoride from α-fluoro-β-alanine. Biochemical Pharmacology. 50(9). 1475–1484. 14 indexed citations
4.
Hulinsky, Ilja, et al.. (1995). In Vitro Growth of Neonatal Rat Islet Cells is Stimulated by Adhesion to Matrix. Hormone and Metabolic Research. 27(5). 209–215. 16 indexed citations
5.
Burnette, Thimysta C., Joan A. Harrington, John E. Reardon, B M Merrill, & P de Miranda. (1995). Purification and Characterization of a Rat Liver Enzyme That Hydrolyzes Valaciclovir, the L-Valyl Ester Prodrug of Acyclovir. Journal of Biological Chemistry. 270(26). 15827–15831. 38 indexed citations
6.
Hulinsky, Ilja, et al.. (1995). Insulin Secretion and DNA Synthesis of Cultured Islets of Langerhans Are Influenced by the Matrix. Pancreas. 11(3). 309–314. 18 indexed citations
7.
Porter, David, et al.. (1994). 5-Ethynyl-2(1H)-pyrimidinone: Aldehyde oxidase-activation to 5-ethynyluracil, a mechanism-based inactivator of dihydropyrimidine dehydrogenase. Biochemical Pharmacology. 47(7). 1165–1171. 14 indexed citations
8.
Porter, David, et al.. (1994). (R)-5-Fluoro-5,6-dihydrouracil: Kinetics of oxidation by dihydropyrimidine dehydrogenase and hydrolysis by dihydropyrimidine aminohydrolase. Biochemical Pharmacology. 48(4). 775–779. 13 indexed citations
9.
Spector, Thomas, Joan A. Harrington, & David Porter. (1993). 5-ethynyluracil (776C85): Inactivation of dihydropyrimidine dehydrogenase in vivo. Biochemical Pharmacology. 46(12). 2243–2248. 88 indexed citations
10.
Harrington, Joan A., John E. Reardon, & T Spector. (1993). 3'-azido-3'-deoxythymidine (AZT) monophosphate: an inhibitor of exonucleolytic repair of AZT-terminated DNA. Antimicrobial Agents and Chemotherapy. 37(4). 918–920. 39 indexed citations
11.
Blumenkopf, Todd A., Joan A. Harrington, Cecilia S. Koble, et al.. (1992). 2-Acetylpyridine thiocarbonohydrazones. Potent inactivators of herpes simplex virus ribonucleotide reductase. Journal of Medicinal Chemistry. 35(12). 2306–2314. 59 indexed citations
12.
Spector, Thomas, Joan A. Harrington, & David Porter. (1991). Herpes and human ribonucleotide reductases. Biochemical Pharmacology. 42(1). 91–96. 26 indexed citations
13.
Harrington, Joan A. & Thomas Spector. (1991). Human ribonucleotide reductase. Biochemical Pharmacology. 42(4). 759–763. 6 indexed citations
14.
Porter, David, Joan A. Harrington, & Thomas Spector. (1990). Herpes simplex virus type 1 ribonucleotide reductase: Selective and synergistic inactivation by a1110u and its iron complex. Biochemical Pharmacology. 39(4). 639–646. 10 indexed citations
15.
Baum, Kenneth F., Randolph L. Berens, J. Joseph Marr, Joan A. Harrington, & T Spector. (1989). Purine deoxynucleoside salvage in Giardia lamblia. Journal of Biological Chemistry. 264(35). 21087–21090. 23 indexed citations
16.
Spector, Thomas & Joan A. Harrington. (1989). Rapid sampling of multiple enzyme reactions. Journal of Virological Methods. 26(2). 237–243. 3 indexed citations
17.
Spector, T, Joan A. Harrington, R.W. Morrison, et al.. (1989). 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.. Proceedings of the National Academy of Sciences. 86(3). 1051–1055. 53 indexed citations
18.
Harrington, Joan A., Wayne H. Miller, & Thomas Spector. (1987). Effector studies of 3′-azidothymidine nucleotides with human ribonucleotide reductase. Biochemical Pharmacology. 36(21). 3757–3761. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026